Quince Therapeutics, Inc. , a late-stage biotechnology company developing an innovative drug delivery technology that leverages a patient’s own biology to deliver rare disease therapeutics, today.
BASEL, Switzerland, Jan. 03, 2024 (GLOBE NEWSWIRE) Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system (CNS) disorders, today announced that members of management will attend and present at two upcoming conferences in San Francisco, CA. SACHS 7th Annual Neuroscience Innovation ForumFormat: Panel DiscussionTitle: Exploring New Modalities for Rare & Orphan Neurological DiseasesDate: Sunday, January 7, 2024 Time: 11:00 a.m. PST (2:00 p.m. EST/8:00 p.m. CE